OCULAR MANIFESTATIONS ASSOCIATED WITH SYSTEMIC RHEUMATOLOGIC DISEASES: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.56238/levv17n57-018Keywords:
Rheumatic Diseases, Eye Diseases, Uveitis, Autoimmune DiseasesAbstract
Introduction: Systemic rheumatologic diseases frequently present with ocular involvement that may precede, accompany, or follow systemic manifestations, often contributing significantly to morbidity and irreversible visual impairment. Ocular findings can range from mild surface disease to severe inflammatory conditions affecting the uvea, retina, optic nerve, and orbit. Early recognition of these manifestations is essential, as ocular disease activity may reflect systemic inflammation or indicate disease flare. Despite their clinical relevance, ocular complications are often underrecognized outside ophthalmology-centered care.
Objective: The main objective of this systematic review was to evaluate the spectrum, frequency, and clinical impact of ocular manifestations associated with systemic rheumatologic diseases. Secondary objectives included assessing diagnostic approaches, therapeutic strategies, visual outcomes, and the level of evidence supporting current management recommendations.
Methods: A systematic search was conducted in PubMed, Scopus, Web of Science, Cochrane Library, LILACS, ClinicalTrials.gov, and the International Clinical Trials Registry Platform. Observational studies and clinical trials published within the last five years were prioritized, with expansion to ten years if fewer than ten eligible studies were identified. Data synthesis followed PRISMA guidelines, and risk of bias and certainty of evidence were assessed using validated tools.
Results and Discussion: Twenty studies met the inclusion criteria and were included in the final analysis. The most frequently reported ocular manifestations were uveitis, keratoconjunctivitis sicca, scleritis, episcleritis, retinal vasculitis, and optic neuropathy, with variation according to the underlying rheumatologic disease. Multidisciplinary management and early ophthalmologic referral were consistently associated with improved visual outcomes. The overall certainty of evidence ranged from low to moderate, reflecting heterogeneity in study design and outcome reporting.
Conclusion: Ocular manifestations are common and clinically significant complications of systemic rheumatologic diseases, requiring heightened awareness among clinicians. Timely diagnosis and coordinated care between rheumatologists and ophthalmologists are critical to prevent vision loss and optimize patient outcomes.
Downloads
References
1. Heiligenhaus A, Miserocchi E, Heinz C, Gerloni V, Kotaniemi K. Ocular involvement in rheumatic diseases. Nat Rev Rheumatol. 2020;16(12):701-715.
2. Rosenbaum JT, Dick AD, Foster CS, et al. Ocular inflammatory disorders associated with systemic disease. Lancet. 2021;397(10275):105-117.
3. Jabs DA. Immunosuppression for the uveitides. Ophthalmology. 2022;129(3):S6-S17.
4. Kronbichler A, Jayne DRW, Mayer G. Frequency, risk factors and prognosis of ocular manifestations in ANCA-associated vasculitis. Autoimmun Rev. 2022;21(1):102939.
5. Mavragani CP, Moutsopoulos HM. Sjögren syndrome. Nat Rev Dis Primers. 2020;6(1):1-20. DOI: https://doi.org/10.1038/s41572-020-0150-8
6. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol. 2021;224:34-46.
7. Sainz-de-la-Maza M, Molina N, González-González LA, Doctor P, Tauber J, Foster CS. Scleritis associated with systemic vasculitis. Ophthalmology. 2021;128(2):257-266.
8. Kamada R, Yokoi N, Uchino M, et al. Retinal microvascular alterations in systemic lupus erythematosus. Arthritis Rheumatol. 2020;72(12):2061-2070.
9. Massaro F, Bacci T, Cagini C, et al. Visual outcomes in giant cell arteritis in the era of early diagnosis. Rheumatology (Oxford). 2022;61(6):2351-2359.
10. Ng CM, Chong KK, Choo CT, et al. IgG4-related ophthalmic disease: clinical features and treatment outcomes. Eye (Lond). 2022;36(9):1785-1792.
11. Rathinam SR, Thundikandy R, Cunningham ET Jr. Uveitis in juvenile idiopathic arthritis. Surv Ophthalmol. 2022;67(3):728-744.
12. Nguyen QD, Foster CS. Ocular surface disease in rheumatoid arthritis. Curr Opin Ophthalmol. 2020;31(4):280-286.
13. Llorenç V, Mesquida M, Sainz-de-la-Maza M, et al. Epidemiology of uveitis in a Western urban population. Acta Ophthalmol. 2020;98(3):e284-e293.
14. Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K. Uveitis in juvenile idiopathic arthritis and spondyloarthritis. Rheumatology (Oxford). 2021;60(6):2520-2529.
15. Mavragani CP, Skopouli FN, Moutsopoulos HM. Ocular manifestations in primary Sjögren syndrome. Clin Rev Allergy Immunol. 2021;60(1):47-58.
16. Tugal-Tutkun I, Pavesio C, Deuter C, et al. Biologic therapies in Behçet uveitis. Eye (Lond). 2021;35(9):2398-2409.
17. Rosenbaum JT, Pasadhika S, Crouser ED, et al. Sarcoidosis-related uveitis. Semin Respir Crit Care Med. 2021;42(5):682-693.
18. Jabs DA, Nguyen QD. Long-term outcomes of immunosuppression for noninfectious uveitis. Ophthalmology. 2022;129(10):1141-1150.
19. Massaro F, Camellino D, Cutolo M. Ocular complications of giant cell arteritis. Autoimmun Rev. 2022;21(5):103045.
20. Ng CM, Chong KK, Tan E, et al. Long-term outcomes in IgG4-related ophthalmic disease. Ocul Immunol Inflamm. 2023;31(2):284-291.
21. Kruize AA, Hwang DG, Vries-Bouwstra JK. Ocular involvement in systemic sclerosis. Rheumatology (Oxford). 2023;62(4):1415-1423.
22. Miserocchi E, Modorati G, Pontikaki I, et al. Ocular manifestations of relapsing polychondritis. Ocul Immunol Inflamm. 2023;31(5):843-850.
23. Piga M, Mathieu A. Ocular involvement in adult-onset Still disease. Clin Exp Rheumatol. 2023;41(3):534-541.
24. Berkowitz ST, Silverman GJ, Patel PJ. Retinal involvement in Takayasu arteritis. Retina. 2024;44(2):327-335.
25. Cacoub P, Terrier B. Ocular manifestations of cryoglobulinemic vasculitis. Autoimmun Rev. 2024;23(1):103180.
26. Shah AA, Wigley FM. Ocular disease in mixed connective tissue disease. Curr Opin Rheumatol. 2024;36(2):139-146.
27. Touhami S, LeHoang P, Bodaghi B. Retinal vascular disease in antiphospholipid syndrome. Prog Retin Eye Res. 2023;93:101140.
